HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function

INTRODUCTION: Hydroxyethyl starch (HES) solutions are widely used for volume replacement therapy but are also known to compromise coagulation, impair renal function and increase long-term mortality. To test the hypotheses that HES 130/0.4 has fewer adverse effects than HES 200/0.5 and exerts anti-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sossdorf, Maik, Marx, Sascha, Schaarschmidt, Barbara, Otto, Gordon P, Claus, Ralf A, Reinhart, Konrad, Hartog, Christiane S, Lösche, Wolfgang
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811952/
https://www.ncbi.nlm.nih.gov/pubmed/20028511
http://dx.doi.org/10.1186/cc8223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811952/
https://www.ncbi.nlm.nih.gov/pubmed/20028511
http://dx.doi.org/10.1186/cc8223

Ejemplares similares